Pipequaline

  Cat. No.:  DC10113   Featured
Chemical Structure
77472-98-1
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Pipequaline (PK 8165) is a partial benzodiazepine receptor agonist with anxiolytic activity.
Cas No.: 77472-98-1
Chemical Name: PK-8165; PK8165; PK 8165
Synonyms: PK-8165; PK8165; PK 8165
SMILES: C1CNCCC1CCC2=CC(=NC3=CC=CC=C32)C4=CC=CC=C4
Formula: C22H24N2
M.Wt: 316.44
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Pipequaline (PK 8165) is a non-selective GABAA receptor partial agonist with anxiolytic activity.
In Vivo: Intravenously administered pipequaline exerts a partial suppression of activations by kainate, glutamate and acetylcholine. Microiontophoretic applications of pipequaline reduces the neuronal activation by kainate[2]. Pipequaline produces dose-related decreases in motor activity. Pipequaline produces significant dose-related decreases in the number of head-dips made[3].
In Vitro: Pipequaline is extensively bound to plasma proteins: i.e. human serum albumin (HSA), alpha-1-acid glycoprotein (AAG), lipoproteins and blood cells, mainly erythrocytes[1].
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC48191 Cipepofol Cipepofol (HSK3486), a sedative-hypnotic agent, is a gamma-aminobutyric acid (GABA) receptor potentiator.
DC9958 U 93631 U93631 is a GABAA receptor ligand of novel chemical structure with IC50 of 100 nM,and has been shown to induce a rapid, time-dependent decay of GABA-induced whole-cell Cl-currents in recombinant GABAA receptors.
DC8896 Tiagabine hydrochloride Tiagabine(NO328) is a selective gamma-aminobutyric acid (GABA) reuptake inhibitor.
DC8099 Saclofen Saclofen is a selective GABAB antagonist.
DC10578 rac BHFF Rac BHFF is a potent and selective GABAB receptor positive allosteric modulator that increases the efficacy and potency of GABA ( > 149% and > 15-fold respectively). Orally active and exhibits anxiolytic activity in vivo.
DC10113 Pipequaline Pipequaline (PK 8165) is a partial benzodiazepine receptor agonist with anxiolytic activity.
DC11267 ONO-8590580 ONO-8590580 is a Novel GABAAα5 Negative Allosteric Modulator Enhances Long-Term Potentiation and Improves Cognitive Deficits in Preclinical Models.
DC8083 NS11394 NS11394 possesses a functional efficacy selectivity profile of alpha(5) > alpha(3) > alpha(2) > alpha(1) at GABA(A) alpha subunit-containing receptors.
DC8642 Lorediplon Lorediplon is a new GABAA modulator Drug for treatment of insomnia.
DC10853 LAU159 LAU159 is a novelα6β3γ2 GABAA receptor inhibitor.
X